Pradaxa to be covered by health insurance

Published: 2012-07-31 07:00:00

Updated: 2012-07-31 07:00:00

Pradaxa (dabigatran etexilate), the blood thinning drug by the German pharmaceutical Company Boehringer Ingleheim, has moved closer to get listed in the national health insurance, with the Health Insurance Review and Assessment Service (HIRA) giving the thumbs-up to do so.

The HIRA acknowledge the indication of Pradaxa to reduce the risk of stroke and systemic embolism in patients with non-v...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.